Ara
Toplam kayıt 5, listelenen: 1-5
Comparison of First and 21st Day anti SARS-CoV-2 anti-spike IgM and IgG Responses
(TURKISH SOC IMMUNOLOGY, 2022)
Objective: There is no definitive information yet about antibody kinetics produced in response to coronavirus disease-2019 (COVID-19) infection. It is essential to know the antibody levels in different patient groups. Our ...
Understanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2)
(Taylor & Francis Group, 08.09.2021)
Covid-19 is a viral disease caused by the virus SARS-CoV-2 that spread worldwide and caused more
than 4.3 million deaths. Moreover, SARS-CoV-2 still continues to evolve, and specifically the E484K,
N501Y, and South Africa ...
Molecular interactions of some phenolics with 2019-nCoV and related pathway elements
(Pamukkale University, 2021)
As of June 2021, the novel coronavirus disease (SARS-CoV-2) resulted in 180 million cases worldwide and resulted in the death of approximately 4 million people. However, an effective pharmaceutical with low side effects ...
COVID-19 Transmission and Clinical Features in Pediatric Intensive Care Health Care Workers
(AVES Yayıncılık, 2022)
Objective: This study aims to investigate modes of transmission and clinical features of coronavirus disease 2019 in healthcare workers in pediatric intensive care units.
Materials and Methods: This multicenter descriptive ...
COVID-19 disease in children presenting to the pediatric emergency department: A multicenter study with 8886 cases from Turkey
(Elsevier, 09.06.2022)
Background
The aim was to evaluate the epidemiological, clinical, laboratory, and radiologic data of children with SARS-CoV-2 positivity by polymerase chain reaction (PCR) together with treatment strategies and clinical ...